Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Demographics

From: Safety and effectiveness of the SUPRACOR presbyopic LASIK algorithm on hyperopic patients

  Supracor + Supracor Supracor + Standard LASIK Supracor + No Treatment P Value
Patients 11 18 29 n/a
Male 3 10 12 n/a
Female 8 8 17
Mean Age (Years) 53.18 ± 3.20 50.56 ± 4.38 50.83 ± 4.68 0.70
UDVA 0.63 ± 0.18 0.43 ± 0.21 0.05 ± 0.06 0.00
UIVA 0.40 ± 0.00 0.40 ± 0.00 0.30 ± 0.12 0.16
UNVA 0.70 ± 0.00 0.68 ± 0.06 0.53 ± 0.22 0.16
Sphere (D) 1.98 ± 0.39 1.97 ± 0.69 1.02 ± 0.52 0.00
Cylinder (D) −0.39 ± 0.26 −0.33 ± 0.33 −0.47 ± 0.49 0.46
Spherical Equivalent (SE) (D) 1.78 ± 0.34 1.81 ± 0.72 0.78 ± 0.48 0.00
  1. UDVA= uncorrected distance visual acuity; UIVA= uncorrected intermediate visual acuity; UNVA= uncorrected near visual acuity